News Opinion Editor's Corner ISCHEMIA Questions? Some Answers From David Maron Shelley Wood December 09, 2019
News Conference News AHA 2019 Dapagliflozin Has Benefits Across Heart Failure Subgroups Todd Neale November 17, 2019
News Conference News AHA 2019 Aspirin Discontinuation Safe, Effective Strategy in ACS Subset: TWILIGHT Yael L. Maxwell November 17, 2019
News Conference News AHA 2019 ISCHEMIA: Invasive Strategy No Better Than Meds for CV Events Shelley Wood November 16, 2019
News Conference News AHA 2019 More Ischemia on Stress Echo Equals Greater Angina Benefit With PCI: ORBITA Michael O'Riordan November 14, 2019
News Conference News VIVA 2019 Calcium Conundrum: New Scores, Research Aim to Boost Outcomes in PAD Interventions L.A. McKeown November 13, 2019
News Opinion Off Script AHA 2019 Off Script: Will ISCHEMIA Answer Our Most Pressing Questions? Ajay Kirtane, MD, SM November 12, 2019
News Conference News AHA 2019 ISCHEMIA Countdown Begins, but a ‘Black-and-White’ Answer Is Uncertain Shelley Wood October 25, 2019
News Daily News Sex-Based Nuances Seen in iFR and FFR Testing: DEFINE-FLAIR Caitlin E. Cox October 24, 2019
News Daily News Ticagrelor Monotherapy After Multivessel PCI? Latest Slice From GLOBAL LEADERS Says . . . Maybe Yael L. Maxwell October 16, 2019
News Daily News Bleeding Risk Similar for Peripheral, Coronary Revascularization: EUCLID Caitlin E. Cox October 16, 2019
News Daily News Believing SCOT-HEART: New Analysis Probes Plausible Mechanisms of Benefit Shelley Wood October 14, 2019
News Daily News Walk and Talk: Step-Counting Devices Work Best When Paired With Doctor Consults Yael L. Maxwell October 10, 2019
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for September 2019 Shelley Wood October 01, 2019
News Conference News TCT 2019 GLOBAL LEADERS Post Hoc: Okay to Drop Aspirin After 1 Month in ACS Patients? Todd Neale September 30, 2019
News Conference News TCT 2019 TWILIGHT: Ticagrelor Monotherapy Lowers Bleeding Without Increasing Ischemic Events Yael L. Maxwell September 26, 2019
News Conference News HFSA 2019 New PROVE-HF Data May Reassure Clinicians of Sacubitril/Valsartan Benefit in HFrEF L.A. McKeown September 18, 2019
News Conference News ESC 2019 For A-fib/PCI Combo, Edoxaban Matches VKA but Not Superior: ENTRUST-AF PCI Todd Neale September 03, 2019
News Conference News ESC 2019 MITRA-FR at 2 Years: Still No Benefit of MitraClip Over Meds Shelley Wood September 02, 2019
News Conference News ESC 2019 AFIRE Supports Rivaroxaban Monotherapy in A-fib Patients With Stable CAD Todd Neale September 02, 2019